RNF208 and metastatic malignant neoplasm: Because Vimentin is associated with the mesenchymal phenotype of aggressive cancer cells in metastatic cancer progression, we first investigated whether RNF208 regulates the expression of EMT markers in Hs578T and MDA-MB-231 cells.